Dr. Kevin L. Garvin, MD

Dr. Garvin practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Garvin's NPI, 1336197698, was assigned on May 5, 2006. Dr. Garvin graduated from Medical College of Wisconsin in 1982. Dr. Garvin holds Nebraska license 17685.

Dr. Garvin's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Garvin also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Garvin's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Garvin is also affiliated with OrthoNebraska Hospital. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Garvin to 1 more hospital and 3 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Garvin practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Garvin's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Garvin is licensed in Nebraska.

CMS data shows 402 Medicare services from Dr. Garvin across 6 procedure codes in 2024, for 299 Medicare patients. Medicare paid $95,899 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 299 Medicare patients who saw Dr. Garvin in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have arthritis, and 71% have high blood pressure. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Garvin's median patient age at 75, with 59% women.

In 2024, Dr. Garvin wrote 802 Medicare Part D claims for 344 patients. 99% of them were for generic drugs. CMS names the drug for 768 of them, across 9 drugs with 11 or more claims each, at $2,624 in total drug cost. In 2023, CMS named 831 claims across 9 drugs.

Dr. Garvin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 59 procedures of knee replacement by Dr. Garvin, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 63 papers to Dr. Garvin, published from 2011 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee and Hip Prosthesis. Dr. Garvin has published most often in J Arthroplasty. Dr. Garvin's most frequent co-authors are Curtis Wayne Hartman, MD, Beau Jackson Kildow, MD and Beau Slavin Konigsberg, MD.

Dmand AI links Dr. Garvin to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Venous Thromboembolism and Pulmonary Embolism.

CMS Open Payments shows 5 general payments to Dr. Garvin from 2 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 90% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $5,301.

Dr. Garvin graduated from Medical College of Wisconsin in 1982.